Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
UNCY
UNCY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
UNCY News
Unicycive Under Investigation for Securities Violations
1d ago
Globenewswire
Unicycive Faces Investor Lawsuit Investigation
6d ago
Globenewswire
Block & Leviton Investigates Unicycive Therapeutics for Securities Violations
Jul 01 2026
Globenewswire
Unicycive's Drug Faces Second FDA Rejection
Jun 30 2026
stocktwits
Unicycive Therapeutics Shares Plunge 37% After FDA Response
Jun 30 2026
seekingalpha
Unicycive Therapeutics Under Investigation Following FDA Response, Stock Declines
Jun 30 2026
Globenewswire
Unicycive Faces Second FDA Rejection for Kidney Drug
Jun 30 2026
stocktwits
Unicycive Receives Complete Response Letter from FDA
Jun 30 2026
NASDAQ.COM
Unicycive Receives Complete Response Letter from FDA
Jun 30 2026
Newsfilter
Unicyive Therapeutics Awaits FDA Decision Amid Bullish Retail Sentiment
Jun 29 2026
stocktwits
Unicyive Therapeutics Faces FDA Decision Amid Stock Volatility
Jun 26 2026
stocktwits
Unicycive's OLC Drug Set for FDA Approval Amid Market Competition
Jun 22 2026
seekingalpha
Trump's Policy Impact on Biopharma Innovation
May 14 2026
seekingalpha
Unicycive Therapeutics Reports Q1 Loss, Misses EPS Estimates
May 12 2026
seekingalpha
Kuehn Law Investigates Unicycive Executives for Fiduciary Breaches
Apr 09 2026
Newsfilter
Kuehn Law Investigates Unicycive Executives for Fiduciary Breaches
Apr 09 2026
PRnewswire
Show More News
